TipRanks
Dexcom (CH:DC4)
:DC4
Switzerland Market
DC4
Dexcom
RESEARCH TOOLSreports

Dexcom (DC4) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

DC4 Analyst Ratings

Strong Buy
19Ratings
Strong Buy
18 Buy
1 Hold
0 Sell
Based on 19 analysts giving stock ratings to
Dexcom
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DC4 Stock 12 Month Forecast

Average Price Target

―
Based on 19 Wall Street analysts offering 12 month price targets for Dexcom in the last 3 months. The average price target is CHF77.01 with a high forecast of CHF86.23 and a low forecast of CHF67.34. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF86.23Average Price TargetCHF77.01Lowest Price TargetCHF67.34
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on CH:DC4
Richard Newitter
Truist Financial
Truist Financial
CHF83.77
Buy
―
Reiterated
09/23/26
Analysts Offer Insights on Healthcare Companies: Dexcom (NASDAQ: DXCM) and Wave Life Sciences (NASDAQ: WVE)
TD Cowen Analyst forecast on CH:DC4
Josh Jennings
TD Cowen
TD Cowen
CHF78.02
Buy
―
Reiterated
09/18/26
Analyst Reaffirms Buy on Dexcom as Stelo App Showcases Successful Shift Toward Consumer Wellness Platform
Wells Fargo Analyst forecast on CH:DC4
Larry Biegelsen
Wells Fargo
Wells Fargo
CHF73.92
Buy
―
Reiterated
09/09/26
Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
Citi Analyst forecast on CH:DC4
Joanne Wuensch
Citi
Citi
CHF72.27→CHF86.23
Buy
―
Reiterated
08/14/26
Citi Reaffirms Their Buy Rating on Dexcom (DXCM)
Mizuho Securities Analyst forecast on CH:DC4
Anthony Petrone
Mizuho Securities
Mizuho Securities
CHF78.02
Buy
―
Reiterated
08/04/26
Mizuho Securities Sticks to Its Buy Rating for Dexcom (DXCM)
J.P. Morgan Analyst forecast on CH:DC4
Robbie Marcus
J.P. Morgan
J.P. Morgan
CHF67.34
Hold
―
Reiterated
08/04/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neuren Pharmaceuticals Limited (Other OTC: NURPF), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)
Canaccord Genuity Analyst forecast on CH:DC4
William Plovanic
Canaccord Genuity
Canaccord Genuity
CHF67.34→CHF73.92
Buy
―
Reiterated
08/03/26
DexCom price target raised to $90 from $82 at CanaccordDexCom price target raised to $90 from $82 at Canaccord
Argus Research Analyst forecast on CH:DC4
Steven Silver
Argus Research
Argus Research
CHF70.63→CHF78.84
Buy
―
Reiterated
08/03/26
Analysts' Top Healthcare Picks: Dexcom (DXCM), AxoGen (AXGN)
William Blair Analyst forecast on CH:DC4
Steven Lichtman
William Blair
William Blair
―
Buy
―
Reiterated
07/31/26
Analyst Reiterates Buy on Dexcom, Citing Strong Q2 Growth, Expanding G7 Adoption and CMS Coverage Upside
Raymond James Analyst forecast on CH:DC4
Jayson Bedford
Raymond James
Raymond James
CHF74.74→CHF77.2
Buy
―
Reiterated
07/31/26
DexCom price target raised to $94 from $91 at Raymond JamesDexCom price target raised to $94 from $91 at Raymond James
Robert W. Baird Analyst forecast on CH:DC4
Jeff Johnson
Robert W. Baird
Robert W. Baird
CHF65.7→CHF86.23
Buy
―
Reiterated
07/31/26
DexCom price target raised to $105 from $80 at BairdDexCom price target raised to $105 from $80 at Baird
Stifel Nicolaus Analyst forecast on CH:DC4
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
CHF73.92→CHF78.02
Buy
―
Assigned
07/31/26
DexCom price target raised to $95 from $90 at StifelDexCom price target raised to $95 from $90 at Stifel
Bank of America Securities Analyst forecast on CH:DC4
Travis Steed
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
07/31/26
Analysts Offer Insights on Healthcare Companies: AptarGroup (NYSE: ATR), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)
Deutsche Bank Analyst forecast on CH:DC4
Kieran Ryan
Deutsche Bank
Deutsche Bank
CHF70.63→CHF75.56
Buy
―
Assigned
07/31/26
DexCom price target raised to $92 from $86 at Deutsche BankDexCom price target raised to $92 from $86 at Deutsche Bank
RBC Capital Analyst forecast on CH:DC4
Kendall Au
RBC Capital
RBC Capital
CHF69.81→CHF73.92
Buy
―
Reiterated
07/31/26
RBC Capital Remains a Buy on Dexcom (DXCM)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on CH:DC4
Richard Newitter
Truist Financial
Truist Financial
CHF83.77
Buy
―
Reiterated
09/23/26
Analysts Offer Insights on Healthcare Companies: Dexcom (NASDAQ: DXCM) and Wave Life Sciences (NASDAQ: WVE)
TD Cowen Analyst forecast on CH:DC4
Josh Jennings
TD Cowen
TD Cowen
CHF78.02
Buy
―
Reiterated
09/18/26
Analyst Reaffirms Buy on Dexcom as Stelo App Showcases Successful Shift Toward Consumer Wellness Platform
Wells Fargo Analyst forecast on CH:DC4
Larry Biegelsen
Wells Fargo
Wells Fargo
CHF73.92
Buy
―
Reiterated
09/09/26
Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
Citi Analyst forecast on CH:DC4
Joanne Wuensch
Citi
Citi
CHF72.27→CHF86.23
Buy
―
Reiterated
08/14/26
Citi Reaffirms Their Buy Rating on Dexcom (DXCM)
Mizuho Securities Analyst forecast on CH:DC4
Anthony Petrone
Mizuho Securities
Mizuho Securities
CHF78.02
Buy
―
Reiterated
08/04/26
Mizuho Securities Sticks to Its Buy Rating for Dexcom (DXCM)
J.P. Morgan Analyst forecast on CH:DC4
Robbie Marcus
J.P. Morgan
J.P. Morgan
CHF67.34
Hold
―
Reiterated
08/04/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neuren Pharmaceuticals Limited (Other OTC: NURPF), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)
Canaccord Genuity Analyst forecast on CH:DC4
William Plovanic
Canaccord Genuity
Canaccord Genuity
CHF67.34→CHF73.92
Buy
―
Reiterated
08/03/26
DexCom price target raised to $90 from $82 at CanaccordDexCom price target raised to $90 from $82 at Canaccord
Argus Research Analyst forecast on CH:DC4
Steven Silver
Argus Research
Argus Research
CHF70.63→CHF78.84
Buy
―
Reiterated
08/03/26
Analysts' Top Healthcare Picks: Dexcom (DXCM), AxoGen (AXGN)
William Blair Analyst forecast on CH:DC4
Steven Lichtman
William Blair
William Blair
―
Buy
―
Reiterated
07/31/26
Analyst Reiterates Buy on Dexcom, Citing Strong Q2 Growth, Expanding G7 Adoption and CMS Coverage Upside
Raymond James Analyst forecast on CH:DC4
Jayson Bedford
Raymond James
Raymond James
CHF74.74→CHF77.2
Buy
―
Reiterated
07/31/26
DexCom price target raised to $94 from $91 at Raymond JamesDexCom price target raised to $94 from $91 at Raymond James
Robert W. Baird Analyst forecast on CH:DC4
Jeff Johnson
Robert W. Baird
Robert W. Baird
CHF65.7→CHF86.23
Buy
―
Reiterated
07/31/26
DexCom price target raised to $105 from $80 at BairdDexCom price target raised to $105 from $80 at Baird
Stifel Nicolaus Analyst forecast on CH:DC4
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
CHF73.92→CHF78.02
Buy
―
Assigned
07/31/26
DexCom price target raised to $95 from $90 at StifelDexCom price target raised to $95 from $90 at Stifel
Bank of America Securities Analyst forecast on CH:DC4
Travis Steed
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
07/31/26
Analysts Offer Insights on Healthcare Companies: AptarGroup (NYSE: ATR), Mettler-Toledo (NYSE: MTD) and Dexcom (NASDAQ: DXCM)
Deutsche Bank Analyst forecast on CH:DC4
Kieran Ryan
Deutsche Bank
Deutsche Bank
CHF70.63→CHF75.56
Buy
―
Assigned
07/31/26
DexCom price target raised to $92 from $86 at Deutsche BankDexCom price target raised to $92 from $86 at Deutsche Bank
RBC Capital Analyst forecast on CH:DC4
Kendall Au
RBC Capital
RBC Capital
CHF69.81→CHF73.92
Buy
―
Reiterated
07/31/26
RBC Capital Remains a Buy on Dexcom (DXCM)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OCULOcular Therapeutix
GHGuardant Health
HROWHarrow Health
DNLIDenali Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dexcom

3 Months
Mike KratkyLeerink Partners
Success Rate
12/18 ratings generated profit
67%
Average Return
+3.93%
Copying Mike Kratky's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +3.93% per trade.
1 Year
Steven LichtmanWilliam Blair
Success Rate
36/50 ratings generated profit
72%
Average Return
+36.37%
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 72.00% of your transactions generating a profit, with an average return of +36.37% per trade.
2 Years
Josh JenningsTD Cowen
Success Rate
17/20 ratings generated profit
85%
Average Return
+10.66%
Copying Josh Jennings's trades and holding each position for 2 Years would result in 85.00% of your transactions generating a profit, with an average return of +10.66% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DC4 Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
4
3
3
0
0
Buy
41
50
64
38
31
Hold
1
1
2
2
2
Sell
2
2
2
0
0
Strong Sell
0
0
0
0
0
total
48
56
71
40
33
In the current month, DC4 has received 31 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. DC4 average Analyst price target in the past 3 months is 77.01.
Each month's total comprises the sum of three months' worth of ratings.

DC4 Financial Forecast

DC4 Earnings Forecast

Next quarter’s earnings estimate for DC4 is CHF0.54 with a range of CHF0.50 to CHF0.57. The previous quarter’s EPS was CHF0.57. DC4 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year DC4 has Performed in-line its overall industry.
Next quarter’s earnings estimate for DC4 is CHF0.54 with a range of CHF0.50 to CHF0.57. The previous quarter’s EPS was CHF0.57. DC4 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year DC4 has Performed in-line its overall industry.

DC4 Sales Forecast

Next quarter’s sales forecast for DC4 is CHF1.07B with a range of CHF1.06B to CHF1.09B. The previous quarter’s sales results were CHF1.06B. DC4 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year DC4 has Performed in-line its overall industry.
Next quarter’s sales forecast for DC4 is CHF1.07B with a range of CHF1.06B to CHF1.09B. The previous quarter’s sales results were CHF1.06B. DC4 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year DC4 has Performed in-line its overall industry.

DC4 Stock Forecast FAQ

What is CH:DC4’s average 12-month price target, according to analysts?
Based on analyst ratings, Dexcom’s 12-month average price target is 77.01.
    What is CH:DC4’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:DC4, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Dexcom a Buy, Sell or Hold?
        Dexcom has a consensus rating of Strong Buy, which is based on 18 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Dexcom’s share price target?
          The average share price target for Dexcom is 77.01. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF86.23 ,and the lowest forecast is CHF67.34. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Dexcom?
            Dexcom’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
              How can I buy shares of Dexcom?
              To buy shares of CH:DC4, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.